{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T16:40:45Z","timestamp":1770136845897,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["NIAID U19AI084081"],"award-info":[{"award-number":["NIAID U19AI084081"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.jcv.2014.06.014","type":"journal-article","created":{"date-parts":[[2014,6,23]],"date-time":"2014-06-23T16:15:41Z","timestamp":1403540141000},"page":"196-198","source":"Crossref","is-referenced-by-count":5,"title":["Human papilloma virions in the laboratory"],"prefix":"10.1016","volume":"61","author":[{"given":"Eileen F.","family":"Dunne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauri E.","family":"Markowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"La'shan D.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth R.","family":"Unger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cosette M.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2014.06.014_bib0005","first-page":"445","article-title":"Generation of HPV pseudovirions using transfection and their use in neutralization assays","volume":"119","author":"Buck","year":"2005","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.jcv.2014.06.014_bib0010","first-page":"1","article-title":"Production of papillomavirus-based gene transfer","volume":"26","author":"Buck","year":"2007","journal-title":"Current Protocols in Cell Biology"},{"key":"10.1016\/j.jcv.2014.06.014_bib0015","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/bjc.2011.185","article-title":"End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24\u201345 years of age","volume":"105","author":"Castellsague","year":"2011","journal-title":"Br J Cancer"},{"issue":"20","key":"10.1016\/j.jcv.2014.06.014_bib0020","first-page":"626","article-title":"FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"CDC","year":"2010","journal-title":"MMWR"},{"issue":"50","key":"10.1016\/j.jcv.2014.06.014_bib0025","first-page":"1705","article-title":"Recommendations on the use of quadrivalent human papillomavirus vaccine in males-Advisory Committee on Immunization Practices (ACIP)","volume":"60","author":"CDC","year":"2011","journal-title":"MMWR"},{"key":"10.1016\/j.jcv.2014.06.014_bib0030","unstructured":"CDC. Biosafety in Microbiological and Biomedical Laboratories (BMBL) 5th Edition accessed October 28, 2013: http:\/\/www.cdc.gov\/biosafety\/publications\/bmbl5\/"},{"key":"10.1016\/j.jcv.2014.06.014_bib0035","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.4161\/cc.8.9.8242","article-title":"A highly efficient system to produce infectious human papillomavirus","volume":"8","author":"Chow","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jcv.2014.06.014_bib0040","doi-asserted-by":"crossref","first-page":"11381","DOI":"10.1128\/JVI.01328-06","article-title":"Papillomavirus particles assembled in 293TT cells are infectious in vivo","volume":"80","author":"Culp","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.jcv.2014.06.014_bib0045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.virol.2005.10.043","article-title":"Induction of productive human papillomavirus type 11 life cycle in epithelial cells grown in organotypic raft cultures","volume":"347","author":"Fang","year":"2006","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.jcv.2014.06.014_bib0050","first-page":"950","article-title":"Human papillomavirus DNA in fomites on objects used for the management of patients with genital human papillomavirus infections","volume":"74","author":"Ferenczy","year":"1989","journal-title":"Obstet Gynecol"},{"issue":"19","key":"10.1016\/j.jcv.2014.06.014_bib0055","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jcv.2014.06.014_bib0060","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1016\/j.vaccine.2011.01.032","article-title":"Considerations for human papillomavirus (HPV) vaccination of mid-adult women in the United States","volume":"29","author":"Grant","year":"2011","journal-title":"Vaccine"},{"issue":"July (7)","key":"10.1016\/j.jcv.2014.06.014_bib0065","doi-asserted-by":"crossref","first-page":"e68329","DOI":"10.1371\/journal.pone.0068329","article-title":"CVT Vaccine Group. Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica","volume":"8","author":"Herrero","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jcv.2014.06.014_bib0070","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jama.298.7.743","article-title":"Vaccine trial group. Effect of human papillomavirus 16\/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial","volume":"298","author":"Hildesheim","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jcv.2014.06.014_bib0075","series-title":"Fields Virology","first-page":"2299","article-title":"Papillomaviruses","author":"Howley","year":"2007"},{"key":"10.1016\/j.jcv.2014.06.014_bib0080","doi-asserted-by":"crossref","first-page":"7169","DOI":"10.1073\/pnas.85.19.7169","article-title":"Human papillomavirus type 16 alters human epithelial cell differentiation in vitro","volume":"85","author":"McCance","year":"1988","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jcv.2014.06.014_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0042-6822(03)00312-X","article-title":"Human papillomavirus type 45 propagation, infection, and neutralization","volume":"312","author":"McLaughlin-Drubin","year":"2003","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.jcv.2014.06.014_bib0090","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.virol.2003.12.019","article-title":"Evidence for the coexistence of two genital tHPV types within the same host cell in vitro","volume":"321","author":"McLaughlin-Drubin","year":"2004","journal-title":"Virology"},{"issue":"10","key":"10.1016\/j.jcv.2014.06.014_bib0095","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.1128\/JVI.71.10.7381-7386.1997","article-title":"Synthesis of infection human papillomavirus type 18 in differentiated epithelium transfected with viral DNA","volume":"71","author":"Meyers","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.jcv.2014.06.014_bib0100","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/jac\/dku006","article-title":"Susceptibility of high-risk human papillomavirus type 16 to clinical disinfectants","volume":"69","author":"Meyers","year":"2014","journal-title":"J Anitmicrob Chemother"},{"issue":"9679","key":"10.1016\/j.jcv.2014.06.014_bib0105","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(09)60691-7","article-title":"Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24\u201345 years: a randomised, double-blind trial","volume":"373","author":"Munoz","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2014.06.014_bib0110","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1099\/0022-1317-83-11-2753","article-title":"Infectious human papillomavirus type 31b: purification and infection of an immortalized human keratinocyte cell line","volume":"83","author":"Ozbun","year":"2002","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jcv.2014.06.014_bib0115","doi-asserted-by":"crossref","first-page":"9311","DOI":"10.1073\/pnas.0504020102","article-title":"Production of infectious human papillomavirus independently of viral replication and epithelial cell differentiation","volume":"102","author":"Pyeon","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.jcv.2014.06.014_bib0120","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1086\/516515","article-title":"Papillomavirus is resistant to desiccation","volume":"176","author":"Roden","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcv.2014.06.014_bib0125","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.virusres.2009.10.019","article-title":"Inducible heat shock protein 70 enhances HPV31 viral genome replication and virion production during the differentiation-dependent life cycle in human keratinocytes","volume":"147","author":"Song","year":"2010","journal-title":"Virus Res"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653214002455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653214002455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T08:06:15Z","timestamp":1597997175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653214002455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1386653214002455"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2014.06.014","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}